Transcriptional dysregulation by a nucleus-localized aminoacyl-tRNA synthetase associated with Charcot-Marie-Tooth neuropathy

Charcot-Marie-Tooth disease (CMT) is a length-dependent peripheral neuropathy. The aminoacyl-tRNA synthetases constitute the largest protein family implicated in CMT. Aminoacyl-tRNA synthetases are predominantly cytoplasmic, but are also present in the nucleus. Here we show that a nuclear function of tyrosyl-tRNA synthetase (TyrRS) is implicated in a Drosophila model of CMT. CMT-causing mutations in TyrRS induce unique conformational changes, which confer capacity for aberrant interactions with transcriptional regulators in the nucleus, leading to transcription factor E2F1 hyperactivation. Using neuronal tissues, we reveal a broad transcriptional regulation network associated with wild-type TyrRS expression, which is disturbed when a CMT-mutant is expressed. Pharmacological inhibition of TyrRS nuclear entry with embelin reduces, whereas genetic nuclear exclusion of mutant TyrRS prevents hallmark phenotypes of CMT in the Drosophila model. These data highlight that this translation factor may contribute to transcriptional regulation in neurons, and suggest a therapeutic strategy for CMT.

Nature Research wishes to improve the reproducibility of the work that we publish. This form provides structure for consistency and transparency in reporting. For further information on Nature Research policies, see Authors & Referees and the Editorial Policy Checklist.

Statistics
For all statistical analyses, confirm that the following items are present in the figure legend, table legend, main text, or Methods section.
n/a Confirmed The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly The statistical test(s) used AND whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals) For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Give P values as exact values whenever suitable.

For Bayesian analysis, information on the choice of priors and Markov chain Monte Carlo settings
For hierarchical and complex designs, identification of the appropriate level for tests and full reporting of outcomes Estimates of effect sizes (e.g. Cohen's d, Pearson's r), indicating how they were calculated Our web collection on statistics for biologists contains articles on many of the points above.

Software and code
Policy information about availability of computer code Data collection RT-PCR data collection utilized StepOnePlus Real Time PCR system (Applied Biosystems) or ViiA 7 software version 1.2.2 (Applied Biosystems). Western blot membrane exposure and data collection utilized FlourChem M (Proteinsimple) or the ImageQuant LAS4000 v1.2 (GE Healthcare). Negative geotaxis was performed using the Flycrawler software (Peira scientific instruments). Image collection was achieved using the ZEN 2011 SP7 v14.0.7.201 (Zeiss) software or Nikon Elements Advance Research 4.
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.

October 2018
Data Policy information about availability of data All manuscripts must include a data availability statement. This statement should provide the following information, where applicable: -Accession codes, unique identifiers, or web links for publicly available datasets -A list of figures that have associated raw data -A description of any restrictions on data availability Source data are provided as a Source Data file. All data generated or analysed during this study are included in this published article (and its supplementary information files). The sequencing data are deposited at the GEO database (GSE125311). All other relevant data are available from the corresponding authors upon request.

Field-specific reporting
Please select the one below that is the best fit for your research. If you are not sure, read the appropriate sections before making your selection.

Life sciences Behavioural & social sciences Ecological, evolutionary & environmental sciences
For a reference copy of the document with all sections, see nature.com/documents/nr-reporting-summary-flat.pdf

Life sciences study design
All studies must disclose on these points even when the disclosure is negative.

Sample size
No sample size determination was performed. For the negative geotaxis assay, 10 repetitive measurements of a group of 10 flies was performed for at least 10 different groups to obtain reproducible results. To assess developmental lethality, at least 300 flies or pupae were counted, arising from 3 independent crosses to obtain reproducible results.
Data exclusions The PCA and the hierarchical clustering of the regularized log counts revealed 3 outlier samples (nSyb-Gal4>+ (11), nSyb-Gal4>TyrRS_WT (12), nSyb-Gal4>TyrRS_WTΔNLS (18)) which were removed from the final differential expression analysis, to avoid bias in the dataset. For the negative geotaxis assay each group of 10 flies was measured 15 times and the average of the 10 fastest walking speeds was calculated. Groups that did not show any climbing behaviour or a wide spread between flies (>4secs) were excluded.

Replication
For the Drosophila experiments, three individual crosses were set up to replicate the findings. RNA sequencing analysis was performed on 4 individual biological replicates originating from individual crosses to account for variability within biological samples. Experiments performed on cells were repeated three times on individual extractions and a representable image is shown.
Randomization Data acquisition for the negative geotaxis assay was performed on an automated system where flies were blindly and randomly placed into the machine and tracked by the system.

Blinding
Data acquisition for the negative geotaxis assay was performed on an automated system where flies were blindly and randomly placed into the machine and tracked by the system.

Reporting for specific materials, systems and methods
We require information from authors about some types of materials, experimental systems and methods used in many studies. Here, indicate whether each material, system or method listed is relevant to your study. If you are not sure if a list item applies to your research, read the appropriate section before selecting a response.

Authentication
The HEK293T cell line was authenticated by morphology check by microscope.

Mycoplasma contamination
The HEK293T cell line was tested negative for mycoplasma contamination. Lymphoblast lines were tested negative for mycoplasma contamination before use.

Commonly misidentified lines (See ICLAC register)
Name any commonly misidentified cell lines used in the study and provide a rationale for their use.

Animals and other organisms
Policy information about studies involving animals; ARRIVE guidelines recommended for reporting animal research

Laboratory animals
For the fly experiments, Drosophila melanogaster was used of the Canton S strain. Female flies were used for all the experiments. This study was approved by the ethical committee for biomedical experiments with animals of the University of Antwerp (EDC 2014-02).

Wild animals
The study did not involve wild animals.

Field-collected samples
The study did not involve samples collected from the field.

Ethics oversight
No ethical approval was required as no new patient samples was obtained and no vertebrate animals were used for this study.
Note that full information on the approval of the study protocol must also be provided in the manuscript.